Alnylam-Sponsored PBS Medical Stories - PH1: Bonded Hope
This film is intended for US audiences. This documentary tells the story of an amazing family with four children, three of whom are impacted by a rare metabolic disease - primary hyperoxaluria type 1, or PH1. Learn about the devastating consequences of PH1, and how for some this genetic disease means having to have a kidney and liver transplantation as a result of an underlying liver defect and severe damage to the kidneys that is typical for patients diagnosed with this progressive disease. PH1-USA-00185

▶︎
Kim – Living with Primary Hyperoxaluria Type 1

▶︎
Alnylam's siRELIS(TM) Enzymatic Ligation Platform

▶︎
Alnylam Challengers: Improving Access to Healthcare in Boston by Investing in Care Navigators

▶︎
A Message from Alnylam CEO Yvonne Greenstreet - Reflecting on 2025 and Looking forward to 2026

▶︎
Marc – Living with Wild-Type ATTR Amyloidosis with Cardiomyopathy

▶︎
The Skinner Family - Living with Primary Hyperoxaluria Type 1 (PH1)

▶︎
Alnylam & RNAi Therapeutics: Making our Medicines

▶︎
RNAi, a promising platform for drug development

▶︎
Physiopathologie de la PHA

▶︎
Alnylam & RNAi Therapeutics: Making our Medicines

▶︎
Alnylam & RNAi Therapeutics: Silencing Disease. Amplifying Life.

▶︎
Alnylam Announces $250 Million Expansion of U.S. RNAi Therapeutics Manufacturing Facility

▶︎
Alnylam Act - No Charge, Third Party Genetic Testing & Counseling

▶︎
